Published in Rheumatology (Oxford) on June 04, 2013
The development and assessment of biological treatments for children. Br J Clin Pharmacol (2015) 0.89
Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database. Arthritis Care Res (Hoboken) (2016) 0.85
Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. Rheumatology (Oxford) (2016) 0.78
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab. Arthritis Res Ther (2016) 0.75
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study. Pediatr Rheumatol Online J (2017) 0.75
Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status. Clin Rheumatol (2017) 0.75
Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ (2002) 5.01
Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen-month, randomized, double-blind, placebo-controlled, crossover trial. Arthritis Rheum (2005) 2.38
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol (2010) 2.35
CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest (2009) 2.15
ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. J Rheumatol (2012) 2.14
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA (2010) 2.02
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis (2006) 1.95
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med (2003) 1.81
Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA (2011) 1.80
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum (2011) 1.79
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis (2007) 1.55
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis (2011) 1.51
Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A (2010) 1.47
Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis. Arthritis Rheum (2002) 1.45
Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol (2008) 1.43
Clinical practice. Protein-losing enteropathy in children. Eur J Pediatr (2010) 1.42
Temporomandibular involvement in juvenile idiopathic arthritis. J Rheumatol (2004) 1.41
Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel. Arthritis Rheum (2004) 1.34
High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum (2011) 1.30
Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood (2010) 1.28
Trends in prescribing antibiotics for children in Dutch general practice. J Antimicrob Chemother (2004) 1.26
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) (2009) 1.26
Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol (2003) 1.23
The OMERACT Ultrasound Group: status of current activities and research directions. J Rheumatol (2007) 1.21
Interventions for impetigo. Cochrane Database Syst Rev (2012) 1.19
Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J Immunol (2008) 1.19
Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum Mutat (2012) 1.19
Aerobic and anaerobic exercise capacity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum (2007) 1.18
The natural course of chronic benign pain in childhood and adolescence: a two-year population-based follow-up study. Eur J Pain (2003) 1.17
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis (2012) 1.16
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis (2012) 1.15
Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol (2003) 1.15
Diagnosis and management of juvenile idiopathic arthritis. BMJ (2010) 1.14
Brief report: Cognitive emotion regulation strategies and psychological adjustment in adolescents with a chronic disease. J Adolesc (2008) 1.14
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online J (2012) 1.11
Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am (2012) 1.11
Increasing incidence of skin disorders in children? A comparison between 1987 and 2001. BMC Dermatol (2006) 1.08
Changing morbidity patterns in children in Dutch general practice: 1987-2001. Eur J Gen Pract (2005) 1.07
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol (2014) 1.04
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online J (2012) 1.04
Approaches to professional behaviour assessment: tools in the professionalism toolbox. Eur J Intern Med (2009) 1.02
Musculoskeletal problems in overweight and obese children. Ann Fam Med (2009) 1.02
Physical activity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.00
Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application. BMC Pediatr (2011) 1.00
Epidemiology of unintentional injuries in childhood: a population-based survey in general practice. Br J Gen Pract (2005) 1.00
Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept. J Rheumatol (2011) 0.98
Variable expression and treatment of PAPA syndrome. Ann Rheum Dis (2011) 0.97
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. Arthritis Rheum (2003) 0.97
Bad apples spoil the barrel: Addressing unprofessional behaviour. Med Teach (2010) 0.96
Promoting physical activity in children with juvenile idiopathic arthritis through an internet-based program: results of a pilot randomized controlled trial. Arthritis Care Res (Hoboken) (2010) 0.96
Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.94
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.94
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010. J Rheumatol (2011) 0.94
Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis. Arthritis Rheum (2008) 0.94
Physically unexplained chronic pain and its impact on children and their families: the mother's perception. Psychol Psychother (2002) 0.93
Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol (2006) 0.93
Long-term followup of temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Rheum (2008) 0.93
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. Ann Rheum Dis (2012) 0.93
Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum (2009) 0.92
Stability of pain parameters and pain-related quality of life in adolescents with persistent pain: a three-year follow-up. Clin J Pain (2002) 0.92
Incidence rates and management of urinary tract infections among children in Dutch general practice: results from a nation-wide registration study. BMC Pediatr (2006) 0.91
Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J (2008) 0.91